Protein structural and sequence analysis of human ACE2 using prediction and modeling bioinformatics tools for diagnostics biomarkers and drug design features: an opinion study path

06 August 2023, Version 1
This content is an early or alternative research output and has not been peer-reviewed by Cambridge University Press at the time of posting.

Abstract

Angiotensin converting enzyme-2 receptor (ACE2) present on human cell membrane surfaces is a critical receptor for binding of SARS-CoV-2 to invade cells. Severe burden of recent COVID-19 pandemic was of global public health importance. Using bioinformatics tools, protein sequence and structural features of ACE2 protein can be obtained. Protein sequences can be compared with structures of ACE2 proteins from same individuals (or patients) of different clinical status. This can either be from data obtained from disease states or already deposited annotated data. Then assess for effectiveness of a pool of bio-molecular attributes such structural neighbor profiles which help describe micro-environment of single amino polymorphisms (SAPs). Then engage predictive and modeling tools to predict key mutational loci- particularly involving SAPs and their functions in relation to disease states. Generated data can contribute to ontology, screens to identify biomarkers and open up paths to development of research protocols in therapeutics and diagnostics.

Keywords

ACE2
critical receptor
protein
diagnostic
structural
13A structural neighbour profile

Comments

Comments are not moderated before they are posted, but they can be removed by the site moderators if they are found to be in contravention of our Commenting and Discussion Policy [opens in a new tab] - please read this policy before you post. Comments should be used for scholarly discussion of the content in question. You can find more information about how to use the commenting feature here [opens in a new tab] .
This site is protected by reCAPTCHA and the Google Privacy Policy [opens in a new tab] and Terms of Service [opens in a new tab] apply.